3Dellinger RP,Levy MM,Carlet JM. Surviving Sepsis Campaign:international guidelines for management of severe sepsis and septic shock:2008[J].Critical Care Medicine,2008.296-327.
4Agrawal A,Gupta A,Consul S. Comparative study of dopamine and norepinephrine in the management of septic shock[J].Saudi J Anaesth,2011.162-166.
5Póvoa PR,Carneiro A H,Ribeiro OS. Influence of vasopressor agent in septic shock mortality.Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study)[J].Critical Care Medicine,2009.410-416.
6De Backer D,Aldecoa C,Njimi H. Dopamine versus norepinephrine in the treatment of septic shock:a meta-analysis[J].Critical Care Medicine,2012.725-730.
7Jadad AR,Moore RA,Carroll D. Assessing the quality of reports of randomized clinical trials:is blinding necessary[J].Controlled Clinical Trials,1996.1-12.
8De Backer D,Biston P,Devriendt J. Comparison of dopamine and norepinephrine in the treatment of shock[J].New England Journal of Medicine,2010.779-789.
9Patel GP,Grahe JS,Sperry M. Efficacy and safety of dopamine versus norepinephrine in the management of septic shock[J].Shock,2010,(4):375-380.doi:10.1097/SHK.0b013e3181c6ba6f.
10Mathur SK,Dhunna R,Chakraborty A. Comparison of norepinephrine and dopamine in the management of septic shock using impedance cardiography[J].INDIAN JOURNAL OF CRITICAL CARE MEDICINE,2007.186-191.
